Title:
A medicine constituent for internal use and a preparing method for the same for the medical treatment of the anaphylactic enteritis syndrome containing an intestinal motility regulation agent, a gas stay prevention agent, and a digestive enzyme
Document Type and Number:
Japanese Patent JP6250100
Kind Code:
B2
Abstract:
The invention relates to a pharmaceutical formulation or composition intended to be administered orally in the form of a tablet, a coated tablet or a capsule, for the prevention or treatment of intestinal disorders, such as irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, digestive enzymes, a binding agent, a diluent, an adsorbent agent, a disintegrating agent, a lubricant and a glidant, effective for normalising colon transit, for providing an analgesic activity, for providing an antispasmodic activity and for reducing symptoms related to intestinal gas, such as distention, abdominal pain and flatulence.
More Like This:
Inventors:
Bernard Escudero Roberto
Savoir Vilvouf John Claude
Savoir Vilvouf John Claude
Application Number:
JP2016116423A
Publication Date:
December 20, 2017
Filing Date:
June 10, 2016
Export Citation:
Assignee:
Posi Visionary Solutions Limited Liability Partnership
International Classes:
A61K31/235; A61K9/20; A61K9/28; A61K9/48; A61K31/80; A61K38/47; A61K47/04; A61K47/26; A61K47/36; A61K47/38; A61P1/14
Domestic Patent References:
| JP2008056567A | ||||
| JP4230329A | ||||
| JP8512322A | ||||
| JP5500043A |
Foreign References:
| US20080038336 |
Other References:
Dig. Dis. Sci., 2007, Vol.52, No.1, p.78-83
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Kazumi Nakamura
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Kazumi Nakamura
Previous Patent: The structure improvement thing of a pump casing using a PFA liner
Next Patent: JPS6250101
Next Patent: JPS6250101